Selected research
Market Structure
Global Peptide Synthesis CDMO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Peptide Synthesis CDMO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Peptide Synthesis CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Peptide Synthesis CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Peptide Synthesis CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Peptide Synthesis CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Peptide Synthesis CDMO Services include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic and ScinoPharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Peptide Synthesis CDMO Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Peptide Synthesis CDMO Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Peptide Synthesis CDMO Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Peptide Synthesis CDMO Services market size, projected growth trends, production technologies, key applications, and end-use industries.
Peptide Synthesis CDMO Services Segment by Company
Bachem
CordenPharma
PolyPeptide
AmbioPharm
Genscript
Thermo Fisher
USV Peptides
Bio Basic
ScinoPharm
JPT
CBL
Piramal Pharma
CPC Scientific
Creative Peptides
Chinese Peptide Company
ChengDu ShengNuo Biotec
AppTec Co., Ltd.
GL Biochem
Peptide Synthesis CDMO Services Segment by Type
GMP Services
Non-GMP Services
Peptide Synthesis CDMO Services Segment by Application
Commercial
Scientific Research
Other
Peptide Synthesis CDMO Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Synthesis CDMO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide Synthesis CDMO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Synthesis CDMO Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Peptide Synthesis CDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peptide Synthesis CDMO Services industry.
Chapter 3: Detailed analysis of Peptide Synthesis CDMO Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide Synthesis CDMO Servicesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Peptide Synthesis CDMO Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032
Table 2. Key Players of GMP Services
Table 3. Key Players of Non-GMP Services
Table 4. Global Peptide Synthesis CDMO Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032
Table 5. Key Players of Commercial
Table 6. Key Players of Scientific Research
Table 7. Key Players of Other
Table 8. Global Peptide Synthesis CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 9. Global Peptide Synthesis CDMO Services Market Size by Region (2021-2026) & (US$ Million)
Table 10. Global Peptide Synthesis CDMO Services Market Share by Region (2021-2026)
Table 11. Global Peptide Synthesis CDMO Services Market Size by Region (2027-2032) & (US$ Million)
Table 12. Global Peptide Synthesis CDMO Services Market Share by Region (2027-2032)
Table 13. Peptide Synthesis CDMO Services Industry Trends
Table 14. Peptide Synthesis CDMO Services Industry Drivers
Table 15. Peptide Synthesis CDMO Services Industry Opportunities and Challenges
Table 16. Peptide Synthesis CDMO Services Industry Restraints
Table 17. Global Peptide Synthesis CDMO Services Revenue by Company (US$ Million) & (2021-2026)
Table 18. Global Peptide Synthesis CDMO Services Revenue Market Share by Company (2021-2026)
Table 19. Global Peptide Synthesis CDMO Services Players Revenue Ranking, 2024 VS 2025 VS 2026
Table 20. Global Peptide Synthesis CDMO Services Key Company Head Office and Area Served
Table 21. Global Peptide Synthesis CDMO Services Company, Product Type & Application
Table 22. Global Peptide Synthesis CDMO Services Company Establishment Date
Table 23. Global Company Market Concentration Ratio (CR5 and HHI)
Table 24. Global Peptide Synthesis CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 25. Global Peptide Synthesis CDMO Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 26. Global Peptide Synthesis CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 27. Global Peptide Synthesis CDMO Services Market Size by Type (2027-2032) & (US$ Million)
Table 28. Global Peptide Synthesis CDMO Services Revenue Market Share by Type (2021-2026)
Table 29. Global Peptide Synthesis CDMO Services Revenue Market Share by Type (2027-2032)
Table 30. Global Peptide Synthesis CDMO Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 31. Global Peptide Synthesis CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 32. Global Peptide Synthesis CDMO Services Market Size by Application (2027-2032) & (US$ Million)
Table 33. Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2021-2026)
Table 34. Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2027-2032)
Table 35. Bachem Company Information
Table 36. Bachem Business Overview
Table 37. Bachem Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 38. Bachem Peptide Synthesis CDMO Services Product Portfolio
Table 39. Bachem Recent Development
Table 40. CordenPharma Company Information
Table 41. CordenPharma Business Overview
Table 42. CordenPharma Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 43. CordenPharma Peptide Synthesis CDMO Services Product Portfolio
Table 44. CordenPharma Recent Development
Table 45. PolyPeptide Company Information
Table 46. PolyPeptide Business Overview
Table 47. PolyPeptide Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 48. PolyPeptide Peptide Synthesis CDMO Services Product Portfolio
Table 49. PolyPeptide Recent Development
Table 50. AmbioPharm Company Information
Table 51. AmbioPharm Business Overview
Table 52. AmbioPharm Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 53. AmbioPharm Peptide Synthesis CDMO Services Product Portfolio
Table 54. AmbioPharm Recent Development
Table 55. Genscript Company Information
Table 56. Genscript Business Overview
Table 57. Genscript Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 58. Genscript Peptide Synthesis CDMO Services Product Portfolio
Table 59. Genscript Recent Development
Table 60. Thermo Fisher Company Information
Table 61. Thermo Fisher Business Overview
Table 62. Thermo Fisher Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 63. Thermo Fisher Peptide Synthesis CDMO Services Product Portfolio
Table 64. Thermo Fisher Recent Development
Table 65. USV Peptides Company Information
Table 66. USV Peptides Business Overview
Table 67. USV Peptides Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 68. USV Peptides Peptide Synthesis CDMO Services Product Portfolio
Table 69. USV Peptides Recent Development
Table 70. Bio Basic Company Information
Table 71. Bio Basic Business Overview
Table 72. Bio Basic Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 73. Bio Basic Peptide Synthesis CDMO Services Product Portfolio
Table 74. Bio Basic Recent Development
Table 75. ScinoPharm Company Information
Table 76. ScinoPharm Business Overview
Table 77. ScinoPharm Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 78. ScinoPharm Peptide Synthesis CDMO Services Product Portfolio
Table 79. ScinoPharm Recent Development
Table 80. JPT Company Information
Table 81. JPT Business Overview
Table 82. JPT Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 83. JPT Peptide Synthesis CDMO Services Product Portfolio
Table 84. JPT Recent Development
Table 85. CBL Company Information
Table 86. CBL Business Overview
Table 87. CBL Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 88. CBL Peptide Synthesis CDMO Services Product Portfolio
Table 89. CBL Recent Development
Table 90. Piramal Pharma Company Information
Table 91. Piramal Pharma Business Overview
Table 92. Piramal Pharma Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 93. Piramal Pharma Peptide Synthesis CDMO Services Product Portfolio
Table 94. Piramal Pharma Recent Development
Table 95. CPC Scientific Company Information
Table 96. CPC Scientific Business Overview
Table 97. CPC Scientific Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 98. CPC Scientific Peptide Synthesis CDMO Services Product Portfolio
Table 99. CPC Scientific Recent Development
Table 100. Creative Peptides Company Information
Table 101. Creative Peptides Business Overview
Table 102. Creative Peptides Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 103. Creative Peptides Peptide Synthesis CDMO Services Product Portfolio
Table 104. Creative Peptides Recent Development
Table 105. Chinese Peptide Company Company Information
Table 106. Chinese Peptide Company Business Overview
Table 107. Chinese Peptide Company Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 108. Chinese Peptide Company Peptide Synthesis CDMO Services Product Portfolio
Table 109. Chinese Peptide Company Recent Development
Table 110. ChengDu ShengNuo Biotec Company Information
Table 111. ChengDu ShengNuo Biotec Business Overview
Table 112. ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 113. ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Product Portfolio
Table 114. ChengDu ShengNuo Biotec Recent Development
Table 115. AppTec Co., Ltd. Company Information
Table 116. AppTec Co., Ltd. Business Overview
Table 117. AppTec Co., Ltd. Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 118. AppTec Co., Ltd. Peptide Synthesis CDMO Services Product Portfolio
Table 119. AppTec Co., Ltd. Recent Development
Table 120. GL Biochem Company Information
Table 121. GL Biochem Business Overview
Table 122. GL Biochem Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 123. GL Biochem Peptide Synthesis CDMO Services Product Portfolio
Table 124. GL Biochem Recent Development
Table 125. North America Peptide Synthesis CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 126. North America Peptide Synthesis CDMO Services Market Size by Type (2027-2032) & (US$ Million)
Table 127. North America Peptide Synthesis CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 128. North America Peptide Synthesis CDMO Services Market Size by Application (2027-2032) & (US$ Million)
Table 129. North America Peptide Synthesis CDMO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 130. North America Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
Table 131. North America Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
Table 132. Europe Peptide Synthesis CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 133. Europe Peptide Synthesis CDMO Services Market Size by Type (2027-2032) & (US$ Million)
Table 134. Europe Peptide Synthesis CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 135. Europe Peptide Synthesis CDMO Services Market Size by Application (2027-2032) & (US$ Million)
Table 136. Europe Peptide Synthesis CDMO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 137. Europe Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
Table 138. Europe Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
Table 139. China Peptide Synthesis CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 140. China Peptide Synthesis CDMO Services Market Size by Type (2027-2032) & (US$ Million)
Table 141. China Peptide Synthesis CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 142. China Peptide Synthesis CDMO Services Market Size by Application (2027-2032) & (US$ Million)
Table 143. Asia Peptide Synthesis CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 144. Asia Peptide Synthesis CDMO Services Market Size by Type (2027-2032) & (US$ Million)
Table 145. Asia Peptide Synthesis CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 146. Asia Peptide Synthesis CDMO Services Market Size by Application (2027-2032) & (US$ Million)
Table 147. Asia Peptide Synthesis CDMO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 148. Asia Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
Table 149. Asia Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
Table 150. South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 151. South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Type (2027-2032) & (US$ Million)
Table 152. South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 153. South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Application (2027-2032) & (US$ Million)
Table 154. South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 155. South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
Table 156. South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
Table 157. Research Programs/Design for This Report
Table 158. Authors List of This Report
Table 159. Secondary Sources
Table 160. Primary Sources
List of Figures
Figure 1. Peptide Synthesis CDMO Services Product Image
Figure 2. Global Peptide Synthesis CDMO Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million)
Figure 3. Global Peptide Synthesis CDMO Services Market Share by Type: 2025 VS 2032
Figure 4. GMP Services Image
Figure 5. Non-GMP Services Image
Figure 6. Global Peptide Synthesis CDMO Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million)
Figure 7. Global Peptide Synthesis CDMO Services Market Share by Application: 2025 VS 2032
Figure 8. Commercial Image
Figure 9. Scientific Research Image
Figure 10. Other Image
Figure 11. Global Peptide Synthesis CDMO Services Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 12. Global Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 13. Global Peptide Synthesis CDMO Services Market Share by Region: 2025 VS 2032
Figure 14. Years Considered
Figure 15. Global Peptide Synthesis CDMO Services Market Share by Players in 2025
Figure 16. Global Top 5 and 10 Peptide Synthesis CDMO Services Players Market Share by Revenue in 2025
Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Peptide Synthesis CDMO Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 19. Global Peptide Synthesis CDMO Services Revenue Market Share by Type (2021-2032)
Figure 20. Global Peptide Synthesis CDMO Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 21. Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2021-2032)
Figure 22. North America Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 23. North America Peptide Synthesis CDMO Services Market Share by Type (2021-2032)
Figure 24. North America Peptide Synthesis CDMO Services Market Share by Application (2021-2032)
Figure 25. North America Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
Figure 26. United States Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 27. Canada Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 28. Mexico Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 29. Europe Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 30. Europe Peptide Synthesis CDMO Services Market Share by Type (2021-2032)
Figure 31. Europe Peptide Synthesis CDMO Services Market Share by Application (2021-2032)
Figure 32. Europe Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
Figure 33. Germany Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 34. France Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 35. U.K. Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 36. Italy Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 37. Russia Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 38. Nordic Countries Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 39. China Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 40. China Peptide Synthesis CDMO Services Market Share by Type (2021-2032)
Figure 41. China Peptide Synthesis CDMO Services Market Share by Application (2021-2032)
Figure 42. Asia Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 43. Asia Peptide Synthesis CDMO Services Market Share by Type (2021-2032)
Figure 44. Asia Peptide Synthesis CDMO Services Market Share by Application (2021-2032)
Figure 45. Asia Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
Figure 46. Japan Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 47. South Korea Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 48. Taiwan Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 50. India Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 51. Australia Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 52. South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 53. South America, Middle East & Africa Peptide Synthesis CDMO Services Market Share by Type (2021-2032)
Figure 54. South America, Middle East & Africa Peptide Synthesis CDMO Services Market Share by Application (2021-2032)
Figure 55. South America, Middle East & Africa Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
Figure 56. Brazil Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 57. South Africa Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 58. Saudi Arabia Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 59. Turkey Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 60. Argentina Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 61. UAE Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 62. Egypt Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 63. Chile Peptide Synthesis CDMO Services Market Size (2021-2032) & (US$ Million)
Figure 64. Research Process
Figure 65. Key Executives Interviewed
Scope & coverage.
Types
- GMP Services
- Non-GMP Services
Applications
- Commercial
- Scientific Research
- Other
Companies covered
- Bachem
- CordenPharma
- PolyPeptide
- AmbioPharm
- Genscript
- Thermo Fisher
- USV Peptides
- Bio Basic
- ScinoPharm
- JPT
- CBL
- Piramal Pharma
- CPC Scientific
- Creative Peptides
- Chinese Peptide Company
- ChengDu ShengNuo Biotec
- AppTec Co., Ltd.
- GL Biochem
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Peptide Synthesis CDMO Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 GMP Services
- 1.2.3 Non-GMP Services
- 1.3 Market Analysis by Application
- 1.3.1 Global Peptide Synthesis CDMO Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Commercial
- 1.3.3 Scientific Research
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Peptide Synthesis CDMO Services Growth Trends by Region
- 1.5.1 Global Peptide Synthesis CDMO Services Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Peptide Synthesis CDMO Services Market Size by Region (2021-2026)
- 1.5.3 Peptide Synthesis CDMO Services Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Peptide Synthesis CDMO Services Market Dynamics
- 2.1 Peptide Synthesis CDMO Services Industry Trends
- 2.2 Peptide Synthesis CDMO Services Industry Drivers
- 2.3 Peptide Synthesis CDMO Services Industry Opportunities and Challenges
- 2.4 Peptide Synthesis CDMO Services Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Peptide Synthesis CDMO Services Revenue by Company (2021-2026)
- 3.2 Global Peptide Synthesis CDMO Services Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Peptide Synthesis CDMO Services Key Company Head office and Area Served
- 3.4 Global Peptide Synthesis CDMO Services Company, Product Type & Application
- 3.5 Global Peptide Synthesis CDMO Services Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Peptide Synthesis CDMO Services Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Peptide Synthesis CDMO Services Players Market Share by Revenue in 2025
- 3.6.3 2025 Peptide Synthesis CDMO Services Tier 1, Tier 2, and Tier 3
4 Peptide Synthesis CDMO Services Market by Type
- 4.1 Global Peptide Synthesis CDMO Services Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Peptide Synthesis CDMO Services Market Size by Type (2021-2032)
- 4.3 Global Peptide Synthesis CDMO Services Market Size Share by Type (2021-2032)
5 Peptide Synthesis CDMO Services Market by Application
- 5.1 Global Peptide Synthesis CDMO Services Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Peptide Synthesis CDMO Services Market Size by Application (2021-2032)
- 5.3 Global Peptide Synthesis CDMO Services Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Bachem
- 6.1.1 Bachem Company Information
- 6.1.2 Bachem Business Overview
- 6.1.3 Bachem Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Bachem Peptide Synthesis CDMO Services Product Portfolio
- 6.1.5 Bachem Recent Developments
- 6.2 CordenPharma
- 6.2.1 CordenPharma Company Information
- 6.2.2 CordenPharma Business Overview
- 6.2.3 CordenPharma Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 CordenPharma Peptide Synthesis CDMO Services Product Portfolio
- 6.2.5 CordenPharma Recent Developments
- 6.3 PolyPeptide
- 6.3.1 PolyPeptide Company Information
- 6.3.2 PolyPeptide Business Overview
- 6.3.3 PolyPeptide Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 PolyPeptide Peptide Synthesis CDMO Services Product Portfolio
- 6.3.5 PolyPeptide Recent Developments
- 6.4 AmbioPharm
- 6.4.1 AmbioPharm Company Information
- 6.4.2 AmbioPharm Business Overview
- 6.4.3 AmbioPharm Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 AmbioPharm Peptide Synthesis CDMO Services Product Portfolio
- 6.4.5 AmbioPharm Recent Developments
- 6.5 Genscript
- 6.5.1 Genscript Company Information
- 6.5.2 Genscript Business Overview
- 6.5.3 Genscript Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Genscript Peptide Synthesis CDMO Services Product Portfolio
- 6.5.5 Genscript Recent Developments
- 6.6 Thermo Fisher
- 6.6.1 Thermo Fisher Company Information
- 6.6.2 Thermo Fisher Business Overview
- 6.6.3 Thermo Fisher Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Thermo Fisher Peptide Synthesis CDMO Services Product Portfolio
- 6.6.5 Thermo Fisher Recent Developments
- 6.7 USV Peptides
- 6.7.1 USV Peptides Company Information
- 6.7.2 USV Peptides Business Overview
- 6.7.3 USV Peptides Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 USV Peptides Peptide Synthesis CDMO Services Product Portfolio
- 6.7.5 USV Peptides Recent Developments
- 6.8 Bio Basic
- 6.8.1 Bio Basic Company Information
- 6.8.2 Bio Basic Business Overview
- 6.8.3 Bio Basic Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Bio Basic Peptide Synthesis CDMO Services Product Portfolio
- 6.8.5 Bio Basic Recent Developments
- 6.9 ScinoPharm
- 6.9.1 ScinoPharm Company Information
- 6.9.2 ScinoPharm Business Overview
- 6.9.3 ScinoPharm Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 ScinoPharm Peptide Synthesis CDMO Services Product Portfolio
- 6.9.5 ScinoPharm Recent Developments
- 6.10 JPT
- 6.10.1 JPT Company Information
- 6.10.2 JPT Business Overview
- 6.10.3 JPT Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 JPT Peptide Synthesis CDMO Services Product Portfolio
- 6.10.5 JPT Recent Developments
- 6.11 CBL
- 6.11.1 CBL Company Information
- 6.11.2 CBL Business Overview
- 6.11.3 CBL Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 CBL Peptide Synthesis CDMO Services Product Portfolio
- 6.11.5 CBL Recent Developments
- 6.12 Piramal Pharma
- 6.12.1 Piramal Pharma Company Information
- 6.12.2 Piramal Pharma Business Overview
- 6.12.3 Piramal Pharma Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Piramal Pharma Peptide Synthesis CDMO Services Product Portfolio
- 6.12.5 Piramal Pharma Recent Developments
- 6.13 CPC Scientific
- 6.13.1 CPC Scientific Company Information
- 6.13.2 CPC Scientific Business Overview
- 6.13.3 CPC Scientific Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 CPC Scientific Peptide Synthesis CDMO Services Product Portfolio
- 6.13.5 CPC Scientific Recent Developments
- 6.14 Creative Peptides
- 6.14.1 Creative Peptides Company Information
- 6.14.2 Creative Peptides Business Overview
- 6.14.3 Creative Peptides Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Creative Peptides Peptide Synthesis CDMO Services Product Portfolio
- 6.14.5 Creative Peptides Recent Developments
- 6.15 Chinese Peptide Company
- 6.15.1 Chinese Peptide Company Company Information
- 6.15.2 Chinese Peptide Company Business Overview
- 6.15.3 Chinese Peptide Company Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Chinese Peptide Company Peptide Synthesis CDMO Services Product Portfolio
- 6.15.5 Chinese Peptide Company Recent Developments
- 6.16 ChengDu ShengNuo Biotec
- 6.16.1 ChengDu ShengNuo Biotec Company Information
- 6.16.2 ChengDu ShengNuo Biotec Business Overview
- 6.16.3 ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Product Portfolio
- 6.16.5 ChengDu ShengNuo Biotec Recent Developments
- 6.17 AppTec Co., Ltd.
- 6.17.1 AppTec Co., Ltd. Company Information
- 6.17.2 AppTec Co., Ltd. Business Overview
- 6.17.3 AppTec Co., Ltd. Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 AppTec Co., Ltd. Peptide Synthesis CDMO Services Product Portfolio
- 6.17.5 AppTec Co., Ltd. Recent Developments
- 6.18 GL Biochem
- 6.18.1 GL Biochem Company Information
- 6.18.2 GL Biochem Business Overview
- 6.18.3 GL Biochem Peptide Synthesis CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 GL Biochem Peptide Synthesis CDMO Services Product Portfolio
- 6.18.5 GL Biochem Recent Developments
7 North America
- 7.1 North America Peptide Synthesis CDMO Services Market Size (2021-2032)
- 7.2 North America Peptide Synthesis CDMO Services Market Size by Type
- 7.2.1 North America Peptide Synthesis CDMO Services Market Size by Type (2021-2026)
- 7.2.2 North America Peptide Synthesis CDMO Services Market Size by Type (2027-2032)
- 7.2.3 North America Peptide Synthesis CDMO Services Market Share by Type (2021-2032)
- 7.3 North America Peptide Synthesis CDMO Services Market Size by Application
- 7.3.1 North America Peptide Synthesis CDMO Services Market Size by Application (2021-2026)
- 7.3.2 North America Peptide Synthesis CDMO Services Market Size by Application (2027-2032)
- 7.3.3 North America Peptide Synthesis CDMO Services Market Share by Application (2021-2032)
- 7.4 North America Peptide Synthesis CDMO Services Market Size by Country
- 7.4.1 North America Peptide Synthesis CDMO Services Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 7.4.3 North America Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
- 7.4.4 North America Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Peptide Synthesis CDMO Services Market Size (2021-2032)
- 8.2 Europe Peptide Synthesis CDMO Services Market Size by Type
- 8.2.1 Europe Peptide Synthesis CDMO Services Market Size by Type (2021-2026)
- 8.2.2 Europe Peptide Synthesis CDMO Services Market Size by Type (2027-2032)
- 8.2.3 Europe Peptide Synthesis CDMO Services Market Share by Type (2021-2032)
- 8.3 Europe Peptide Synthesis CDMO Services Market Size by Application
- 8.3.1 Europe Peptide Synthesis CDMO Services Market Size by Application (2021-2026)
- 8.3.2 Europe Peptide Synthesis CDMO Services Market Size by Application (2027-2032)
- 8.3.3 Europe Peptide Synthesis CDMO Services Market Share by Application (2021-2032)
- 8.4 Europe Peptide Synthesis CDMO Services Market Size by Country
- 8.4.1 Europe Peptide Synthesis CDMO Services Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 8.4.3 Europe Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
- 8.4.4 Europe Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Peptide Synthesis CDMO Services Market Size (2021-2032)
- 9.2 China Peptide Synthesis CDMO Services Market Size by Type
- 9.2.1 China Peptide Synthesis CDMO Services Market Size by Type (2021-2026)
- 9.2.2 China Peptide Synthesis CDMO Services Market Size by Type (2027-2032)
- 9.2.3 China Peptide Synthesis CDMO Services Market Share by Type (2021-2032)
- 9.3 China Peptide Synthesis CDMO Services Market Size by Application
- 9.3.1 China Peptide Synthesis CDMO Services Market Size by Application (2021-2026)
- 9.3.2 China Peptide Synthesis CDMO Services Market Size by Application (2027-2032)
- 9.3.3 China Peptide Synthesis CDMO Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Peptide Synthesis CDMO Services Market Size (2021-2032)
- 10.2 Asia Peptide Synthesis CDMO Services Market Size by Type
- 10.2.1 Asia Peptide Synthesis CDMO Services Market Size by Type (2021-2026)
- 10.2.2 Asia Peptide Synthesis CDMO Services Market Size by Type (2027-2032)
- 10.2.3 Asia Peptide Synthesis CDMO Services Market Share by Type (2021-2032)
- 10.3 Asia Peptide Synthesis CDMO Services Market Size by Application
- 10.3.1 Asia Peptide Synthesis CDMO Services Market Size by Application (2021-2026)
- 10.3.2 Asia Peptide Synthesis CDMO Services Market Size by Application (2027-2032)
- 10.3.3 Asia Peptide Synthesis CDMO Services Market Share by Application (2021-2032)
- 10.4 Asia Peptide Synthesis CDMO Services Market Size by Country
- 10.4.1 Asia Peptide Synthesis CDMO Services Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 10.4.3 Asia Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
- 10.4.4 Asia Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Type
- 11.2.1 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Application
- 11.3.1 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country
- 11.4.1 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Peptide Synthesis CDMO Services Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst